Metabolic dysfunction-associated steatotic liver disease (MASLD) and its progressive form, metabolic dysfunction-associated steatohepatitis (MASH ...

Steatotic liver disease (commonly called fatty liver disease) progresses silently. Even in the absence of noticeable symptoms ...

Explore the rising concern of MASLD in India, emphasizing the need for proactive screening and lifestyle changes for ...

The sodium glucose cotransporter 2 (SGLT-2) inhibitor drug dapagliflozin, widely used to treat type 2 diabetes, also shows improvements for patients with progressive liver disease, finds a clinical ...

New data links the liver receptor GPR110 to sex-specific progression of metabolic dysfunction-associated steatohepatitis.

Elizabeth Cooney is a cardiovascular disease reporter at STAT, covering heart, stroke, and metabolic conditions. You can reach Liz on Signal at LizC.22. Right now, patients with obesity and cirrhosis ...

Newly discovered mechanism by which oral bacteria affect gut health coincides with worsening liver health in patients with ...

OrsoBio has announced the publication in Nature Medicine of Phase I clinical trial data for TLC-2716, an oral liver-targeted ...

This large-scale UK Biobank study of 89,935 individuals with MASLD demonstrates that accelerated biological aging—measured by ...

Fatty liver disease is a health condition in which fat builds up in the liver. This fat buildup can cause inflammation and, in severe cases, liver damage. There are two main types of fatty liver ...